Financial VDD for Unither as part of its 5th LBO

The management team led by Éric Goupil is putting together a consortium to acquire Unither Pharmaceuticals from Ardian. The consortium consists of GIC, Ik Partners, Keensight Capital, Parquest and the management team.

Headquartered in Amiens, France, Unither employs more than 1,600 people in seven production plants in France, the United States, Brazil and China, as well as in a development centre in Bordeaux. Its products are sold in over 100 countries, demonstrating Unither’s strong international presence. The company benefits from a long-standing and loyal customer base of medium-sized and large pharmaceutical companies, biotechnology companies, generic manufacturers and specialists in the sale of family medication products. It is recognised for its technical expertise and industrial performance, has demonstrated strong organic growth and, thanks to Ardian’s support, has expanded its presence in China to meet the expectations of a market with high demand for BFS products.

This transaction will enable Unither to sustain its growth, expand its presence in the US market and broaden its product offering, particularly in the area of preservative-free multi-dose products, as well as in BFS technology by extending it to vaccines.

The Eight Advisory team consisted of Katia Wagner and Baptiste Piasentin.